However, patients with G/C alleles of IL-18 -137 were correlated with a lower clinical stage
(AOR=0.59; 95% CI=0.39-0.89; p=0.01), smaller tumor size (AOR=0.56; 95% CI=0.35-0.87; p=0.01), and non-lymph
node metastasis (AOR=0.51; 95% CI=0.32-0.80; p=0.003).